We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $168M
1-Year Est. Return 60.36%
This Fund
S&P 500
This Quarter Est. Return
+8.8%
1 Year Est. Return
+60.36%
3 Year Est. Return
+143.93%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$285M
AUM Growth
+$33.9M
Cap. Flow
-$13.6M
Cap. Flow %
-4.76%
Top 10 Hldgs %
67.96%
Holding
105
New
6
Increased
8
Reduced
23
Closed
13

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$2.84M
2
JAAA icon
Janus Henderson AAA CLO ETF
JAAA
+$1.6M
3
LXRX icon
Lexicon Pharmaceuticals
LXRX
+$890K
4
ZIMV
ZimVie
ZIMV
+$642K
5
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$515K

Top Sells

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$7.16M
2
VKTX icon
Viking Therapeutics
VKTX
+$2.17M
3
LK
Luckin Coffee Inc. American Depositary Shares
LK
+$2.11M
4
ICLO icon
Invesco AAA CLO Floating Rate Note ETF
ICLO
+$1.25M
5
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$876K

Sector Composition

Rank Sector Weight
1 Healthcare 30.38%
2 Materials 27.67%
3 Financials 18.32%
4 Communication Services 6.88%
5 Technology 3.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GEV icon
101
GE Vernova
GEV
$254B
– –
-37
Closed -$6K
LK
102
DELISTED
Luckin Coffee Inc. American Depositary Shares
LK
– –
-100,000
Closed -$2.11M
1 2 3 4
5

Similar funds

DI
Disciplined Investors Waco, Texas $168M AUM 23.6% 1-Year Est. Return
WFS
Widmann Financial Services Bowie, Maryland $168M AUM 24.36% 1-Year Est. Return
CCG
Catalina Capital Group Torrance, California $168M AUM 16.69% 1-Year Est. Return
7CM
7G Capital Management New York $168M AUM 45.68% 1-Year Est. Return
MAG
Meadowbrook Advisors Group Bedminster, New Jersey $168M AUM
PFA
Presper Financial Architects Akron, Ohio $168M AUM 12.94% 1-Year Est. Return
CW
Code Waechter Tampa, Florida $168M AUM 15.56% 1-Year Est. Return
IWA
Integrity Wealth Advisors Ventura, California $168M AUM 18.33% 1-Year Est. Return

David M. Knott Jr's Q3 2024 Portfolio in Review

As of Q3 2024, David M. Knott Jr held 105 positions worth $285M, up 14% from $251M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

David M. Knott Jr withdrew a net $13.6M in Q3 2024, closing 13 positions and reducing 23 holdings. Its most notable exit was Ligand Pharmaceuticals, an estimated $7.16M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 31% a quarter earlier, followed by Materials and Financials.

Against the trend, David M. Knott Jr opened a new position in BioMarin Pharmaceuticals worth $2.39M.

  • David M. Knott Jr's largest Q3 2024 buy was BioMarin Pharmaceuticals: 34,000 shares worth $2.39M.
  • David M. Knott Jr added most to Janus Henderson AAA CLO ETF in Q3 2024, an estimated $1.6M increase.
  • David M. Knott Jr's biggest Q3 2024 reduction was Viking Therapeutics, cutting an estimated $2.17M.
  • David M. Knott Jr fully exited Ligand Pharmaceuticals in Q3 2024, selling an estimated $7.16M.
  • David M. Knott Jr's ten largest holdings make up 68% of its $285M portfolio in Q3 2024.
  • David M. Knott Jr opened 6 new positions and closed 13 in Q3 2024.
  • David M. Knott Jr's portfolio value rose 14% quarter-over-quarter to $285M.

Based on David M. Knott Jr's 13F filing for Q3 2024, filed 13 Nov 2024.